Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

Evoque and Patisiran: A Tale of Two Regulatory Journeys

News Opinion Off Script

Evoque and Patisiran: A Tale of Two Regulatory Journeys

Sanjay Kaul, MD

March 29, 2024

Renal Denervation a Third Option for Hypertension, European Experts Say

News Daily News

Renal Denervation a Third Option for Hypertension, European Experts Say

September 17, 2021

New Data Add to Resurgent Renal Denervation Field

News Conference News EuroPCR 2020

New Data Add to Resurgent Renal Denervation Field

June 26, 2020

Renal Denervation Lowers BP Across High-risk Groups: Global SYMPLICITY Registry

News Daily News

Renal Denervation Lowers BP Across High-risk Groups: Global SYMPLICITY Registry

June 09, 2020

Renal Denervation Lowers BP in Pivotal SPYRAL HTN-OFF MED Trial

News Conference News ACC 2020

Renal Denervation Lowers BP in Pivotal SPYRAL HTN-OFF MED Trial

March 30, 2020

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

News Daily News

‘People Are Pretty Optimistic’ as Renal Denervation’s Comeback Continues

June 24, 2019

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

News Daily News

FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies

Michael O'Riordan

December 06, 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

News Conference News TCT 2018

Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO

September 21, 2018

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

Presentation EuroPCR 2018

Renal Denervation in the Presence of Antihypertensive Medications: Six-month Results from the Randomized, Blinded, Sham-controlled SPYRAL HTN-ON MED Trial

Presenter: David E. Kandzari

May 23, 2018

Prominent Investigator Takes Post at Medtronic as Pivotal Renal Denervation Trial Is Announced

News Daily News

Prominent Investigator Takes Post at Medtronic as Pivotal Renal Denervation Trial Is Announced

April 12, 2018

News Industry News

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

April 09, 2018

Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field

News Conference News ESC 2017

Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field

August 28, 2017

News Features

Future of Renal Denervation May Hinge on a Handful of Small Studies

February 14, 2016

News Industry News

Medtronic Announces New SPYRAL HTN Global Clinical Trial Program for Renal Denervation

April 01, 2015

News Industry News

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

December 16, 2013

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.